1-3 of 3
Yvonne Y Chen
Close
Sort by
Journal Articles

A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Sarah M. Larson, Yvonne Y Chen, Jim Johnston, Sylvain Roy, Pinakin Patel, Jonathan E Benjamin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6892.
https://doi.org/10.1182/blood-2023-187614
Published: 2023
Journal Articles

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Benjamin R Puliafito, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Melanie Ayala Ceja, Christy Sidhu, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Karla Nawaly, Martin S Allen-Auerbach, Jonathan Said, Monica Mead, Sven de Vos, Patricia A. Young, Caspian H. Oliai, Gary J. Schiller, John Timmerman, Antoni Ribas, Yvonne Y Chen, Sarah M. Larson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3490.
https://doi.org/10.1182/blood-2023-186636
Published: 2023
Journal Articles

The Non-Signaling Extracellular Spacer Domain of CD19-Specific Chimeric Antigen Receptors Is Decisive for in Vivo Anti-Tumor Activity

Michael Hudecek, MD, Anne Silva, MD, Paula L. Kosasih, BSc, Yvonne Y. Chen, PhD, Cameron J. Turtle, MBBS, PhD, Michael C. Jensen, MD, Stanley R. Riddell, MD
Journal: Blood
Blood (2012) 120 (21): 951.
https://doi.org/10.1182/blood.V120.21.951.951
Published: 2012